Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
BCBS Kansas City Medical Policy Updates – October 2024
Stay ahead in medical policy monitoring and tracking with personalized reports and a real-time dashboard tailored to specific products, procedures, or codes. For those seeking a more impactful solution than Policy Reporter, our platform delivers comprehensive data analytic tools, user-friendly dashboard and collaboration features, client-focused solutions, and real-time email alerts.
Schedule a demo to see how our focused reports save time and provide actionable insights for your reimbursement and commercialization efforts.
Click here to view the Blue Cross Blue Shield BCBS Kansas City Medical Policy Updates »
October 2024 BCBS Kansas City Medical Policy Updates:
- Adjunctive Techniques for Screening and Surveillance of Barrett Esophagus and Esophageal Dysplasia
- Allogeneic Pancreas Transplant
- Balloon Dilation of the Eustachian Tube
- Biochemical Markers of Alzheimer Disease and Dementia
- Biofeedback as a Treatment of Urinary Incontinence in Adults
- Biofeedback for Miscellaneous Indications
- Biomarker Testing for Autoimmune Rheumatic Disease
- Brexanolone and Zuranolone for Postpartum Depression
- Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
- Catheter Ablation as Treatment for Atrial Fibrillation
- Chromosomal Microarray and Low-pass Whole Genome Sequencing
- Colorectal Cancer
- Cooling Devices Used in the Outpatient Setting
- Corneal Topography Computer-Assisted Corneal Topography Photokeratoscopy
- Diagnosis of Vaginitis
- Gene Expression Profiling and Protein Biomarkers for Prostate Cancer
- General Genetic TestingSomatic Disorders
- Genetic Markers for Assessing Risk of Cardiovascular Disease
- Genetic Testing and Genetic Expression Profiling in Patients with Uveal Melanoma
- Genetic Testing for Alpha- and Beta- Thalassemia
- Genetic Testing for BreastOvarianPancreaticand Prostate Cancers (BRCA)
- Genetic Testing for Cystic Fibrosis
- Genetic Testing for Diagnosis of Inherited Peripheral Neuropathies
- Genetic Testing for Epilepsy
- Genetic Testing for Familial Hypercholesterolemia
- Genetic Testing for Hereditary Hearing Loss
- Genetic Testing for Hereditary Pancreatitis
- Genetic Testing for Lactase Insufficiency
- Genetic Testing for Li-Fraumeni Syndrome
- Genetic Testing for Neurofibromatosis and Related Disorders
- Genetic Testing for Ophthalmologic Conditions
- Genetic Testing for Polyposis Syndromes
- Genetic Testing for PTEN Hamartoma Tumor Syndrome
- Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
- Laboratory Procedures Reimbursement Policy
- Liquid Biopsy
- Lynch Syndrome
- Microsatellite Instability and Tumor Mutational Burden Testing
- Minimal Residual Disease
- Molecular Analysis for Gliomas
- Molecular Profiling for Cancers of Unknown Primary Origin
- Molecular Testing for Pulmonary Disease
- Nutrient Nutritional Panel Testing
- Omidubicel as Adjunct Treatment for Hematologic Malignancies
- Panniculectomy and Abdominoplasty
- Pathogen Panel Testing
- Pharmacogenetic Testing
- Prenatal Screening (Genetic)
- Proteogenomic Testing of Individuals with Cancer
- Red Blood Cell Molecular Testing
- Salivary Hormone Testing
- Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases
- Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease
- Testing for Colorectal Cancer Management
- Testing for Targeted Therapy of Non-Small-Cell Lung Cancer
- Transcatheter Mitral Valve Repair or Replacement
- Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric Neurologic Disorders
- Transplant Rejection Testing
- Treatment of Nasal Obstruction
- Trigger Point and Tender Point Injections
- Tumor-Infiltrating Lymphocytes for Advanced Melanoma
- Use of Common Genetic Variants (single nucleotide polymorphisms) to Predict Risk of Non-Familial Breast Cancer
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup
Related Posts
